Treatment adherence by personalizing the drug dispensing for diabetic patients in social vulnerable situation
- Autores
- Marín, Gustavo Horacio; Risso, Paula; Sbattella, Daniela; Haag, Griselda Octavia
- Año de publicación
- 2015
- Idioma
- inglés
- Tipo de recurso
- artículo
- Estado
- versión publicada
- Descripción
- Objectives: We examined the impact of personalizing antidiabetic agents in treatment adherence and in health outcome of socioeconomic vulnerable patients. Methods: We conducted a randomized controlled trial comparing usual “on demand” drug supply from Primary Health Care (PHC) Centers; with a drug dispensing strategy based on a personalized process. 469 patients with type-2 diabetes (DBT) were assigned to either control (CG) or intervention group (IG) assuring a balance in main risk factors. Primary trial endpoint was treatment compliance; however aspects like health events associated to DBT were also evaluated. Results: Adherence to oral agents in CG was 15.57% and 92.09% in IG (p <0.001). Dose omissions represented the most prevalent form of non-adherence. Weight loss was greater in the intervention group than in the control group throughout the study (5.4% in overall weight reduction at study end). Hospital admissions (16.80% vs 10.23% - p <0.01) and coronary heart events (7.37% vs. 3.72% p 0.03) were higher for CG when compared with IG. Conclusions: Diabetes faces the challenge of lifelong treatment. This task is difficult for every patient but is especially hard in social vulnerable situation. Our initiative demonstrate that for the poor and uninsured population, personalizing drug dispensing showed a high level of treatment compliance, and benefits in terms of health consequences associated to diabetes. This experience might be useful for primary care health teams in order to better control social underserved patients, and also for reducing the economical impact for health system caused by complications due to untreated diabetes
Facultad de Ciencias Médicas - Materia
-
Salud
Ciencias Médicas
diabetes
Personalized
Treatment
Adherence
Primary health care - Nivel de accesibilidad
- acceso abierto
- Condiciones de uso
- http://creativecommons.org/licenses/by/4.0/
- Repositorio
- Institución
- Universidad Nacional de La Plata
- OAI Identificador
- oai:sedici.unlp.edu.ar:10915/127605
Ver los metadatos del registro completo
id |
SEDICI_ec1b0641b1f521d050ecb9ea4cb3f5d3 |
---|---|
oai_identifier_str |
oai:sedici.unlp.edu.ar:10915/127605 |
network_acronym_str |
SEDICI |
repository_id_str |
1329 |
network_name_str |
SEDICI (UNLP) |
spelling |
Treatment adherence by personalizing the drug dispensing for diabetic patients in social vulnerable situationMarín, Gustavo HoracioRisso, PaulaSbattella, DanielaHaag, Griselda OctaviaSaludCiencias MédicasdiabetesPersonalizedTreatmentAdherencePrimary health careObjectives: We examined the impact of personalizing antidiabetic agents in treatment adherence and in health outcome of socioeconomic vulnerable patients. Methods: We conducted a randomized controlled trial comparing usual “on demand” drug supply from Primary Health Care (PHC) Centers; with a drug dispensing strategy based on a personalized process. 469 patients with type-2 diabetes (DBT) were assigned to either control (CG) or intervention group (IG) assuring a balance in main risk factors. Primary trial endpoint was treatment compliance; however aspects like health events associated to DBT were also evaluated. Results: Adherence to oral agents in CG was 15.57% and 92.09% in IG (p <0.001). Dose omissions represented the most prevalent form of non-adherence. Weight loss was greater in the intervention group than in the control group throughout the study (5.4% in overall weight reduction at study end). Hospital admissions (16.80% vs 10.23% - p <0.01) and coronary heart events (7.37% vs. 3.72% p 0.03) were higher for CG when compared with IG. Conclusions: Diabetes faces the challenge of lifelong treatment. This task is difficult for every patient but is especially hard in social vulnerable situation. Our initiative demonstrate that for the poor and uninsured population, personalizing drug dispensing showed a high level of treatment compliance, and benefits in terms of health consequences associated to diabetes. This experience might be useful for primary care health teams in order to better control social underserved patients, and also for reducing the economical impact for health system caused by complications due to untreated diabetesFacultad de Ciencias Médicas2015info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArticulohttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdf93-96http://sedici.unlp.edu.ar/handle/10915/127605enginfo:eu-repo/semantics/altIdentifier/issn/1479-1064info:eu-repo/semantics/altIdentifier/issn/1479-1072info:eu-repo/semantics/openAccesshttp://creativecommons.org/licenses/by/4.0/Creative Commons Attribution 4.0 International (CC BY 4.0)reponame:SEDICI (UNLP)instname:Universidad Nacional de La Platainstacron:UNLP2025-09-29T11:30:52Zoai:sedici.unlp.edu.ar:10915/127605Institucionalhttp://sedici.unlp.edu.ar/Universidad públicaNo correspondehttp://sedici.unlp.edu.ar/oai/snrdalira@sedici.unlp.edu.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:13292025-09-29 11:30:53.002SEDICI (UNLP) - Universidad Nacional de La Platafalse |
dc.title.none.fl_str_mv |
Treatment adherence by personalizing the drug dispensing for diabetic patients in social vulnerable situation |
title |
Treatment adherence by personalizing the drug dispensing for diabetic patients in social vulnerable situation |
spellingShingle |
Treatment adherence by personalizing the drug dispensing for diabetic patients in social vulnerable situation Marín, Gustavo Horacio Salud Ciencias Médicas diabetes Personalized Treatment Adherence Primary health care |
title_short |
Treatment adherence by personalizing the drug dispensing for diabetic patients in social vulnerable situation |
title_full |
Treatment adherence by personalizing the drug dispensing for diabetic patients in social vulnerable situation |
title_fullStr |
Treatment adherence by personalizing the drug dispensing for diabetic patients in social vulnerable situation |
title_full_unstemmed |
Treatment adherence by personalizing the drug dispensing for diabetic patients in social vulnerable situation |
title_sort |
Treatment adherence by personalizing the drug dispensing for diabetic patients in social vulnerable situation |
dc.creator.none.fl_str_mv |
Marín, Gustavo Horacio Risso, Paula Sbattella, Daniela Haag, Griselda Octavia |
author |
Marín, Gustavo Horacio |
author_facet |
Marín, Gustavo Horacio Risso, Paula Sbattella, Daniela Haag, Griselda Octavia |
author_role |
author |
author2 |
Risso, Paula Sbattella, Daniela Haag, Griselda Octavia |
author2_role |
author author author |
dc.subject.none.fl_str_mv |
Salud Ciencias Médicas diabetes Personalized Treatment Adherence Primary health care |
topic |
Salud Ciencias Médicas diabetes Personalized Treatment Adherence Primary health care |
dc.description.none.fl_txt_mv |
Objectives: We examined the impact of personalizing antidiabetic agents in treatment adherence and in health outcome of socioeconomic vulnerable patients. Methods: We conducted a randomized controlled trial comparing usual “on demand” drug supply from Primary Health Care (PHC) Centers; with a drug dispensing strategy based on a personalized process. 469 patients with type-2 diabetes (DBT) were assigned to either control (CG) or intervention group (IG) assuring a balance in main risk factors. Primary trial endpoint was treatment compliance; however aspects like health events associated to DBT were also evaluated. Results: Adherence to oral agents in CG was 15.57% and 92.09% in IG (p <0.001). Dose omissions represented the most prevalent form of non-adherence. Weight loss was greater in the intervention group than in the control group throughout the study (5.4% in overall weight reduction at study end). Hospital admissions (16.80% vs 10.23% - p <0.01) and coronary heart events (7.37% vs. 3.72% p 0.03) were higher for CG when compared with IG. Conclusions: Diabetes faces the challenge of lifelong treatment. This task is difficult for every patient but is especially hard in social vulnerable situation. Our initiative demonstrate that for the poor and uninsured population, personalizing drug dispensing showed a high level of treatment compliance, and benefits in terms of health consequences associated to diabetes. This experience might be useful for primary care health teams in order to better control social underserved patients, and also for reducing the economical impact for health system caused by complications due to untreated diabetes Facultad de Ciencias Médicas |
description |
Objectives: We examined the impact of personalizing antidiabetic agents in treatment adherence and in health outcome of socioeconomic vulnerable patients. Methods: We conducted a randomized controlled trial comparing usual “on demand” drug supply from Primary Health Care (PHC) Centers; with a drug dispensing strategy based on a personalized process. 469 patients with type-2 diabetes (DBT) were assigned to either control (CG) or intervention group (IG) assuring a balance in main risk factors. Primary trial endpoint was treatment compliance; however aspects like health events associated to DBT were also evaluated. Results: Adherence to oral agents in CG was 15.57% and 92.09% in IG (p <0.001). Dose omissions represented the most prevalent form of non-adherence. Weight loss was greater in the intervention group than in the control group throughout the study (5.4% in overall weight reduction at study end). Hospital admissions (16.80% vs 10.23% - p <0.01) and coronary heart events (7.37% vs. 3.72% p 0.03) were higher for CG when compared with IG. Conclusions: Diabetes faces the challenge of lifelong treatment. This task is difficult for every patient but is especially hard in social vulnerable situation. Our initiative demonstrate that for the poor and uninsured population, personalizing drug dispensing showed a high level of treatment compliance, and benefits in terms of health consequences associated to diabetes. This experience might be useful for primary care health teams in order to better control social underserved patients, and also for reducing the economical impact for health system caused by complications due to untreated diabetes |
publishDate |
2015 |
dc.date.none.fl_str_mv |
2015 |
dc.type.none.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Articulo http://purl.org/coar/resource_type/c_6501 info:ar-repo/semantics/articulo |
format |
article |
status_str |
publishedVersion |
dc.identifier.none.fl_str_mv |
http://sedici.unlp.edu.ar/handle/10915/127605 |
url |
http://sedici.unlp.edu.ar/handle/10915/127605 |
dc.language.none.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
info:eu-repo/semantics/altIdentifier/issn/1479-1064 info:eu-repo/semantics/altIdentifier/issn/1479-1072 |
dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/4.0/ Creative Commons Attribution 4.0 International (CC BY 4.0) |
eu_rights_str_mv |
openAccess |
rights_invalid_str_mv |
http://creativecommons.org/licenses/by/4.0/ Creative Commons Attribution 4.0 International (CC BY 4.0) |
dc.format.none.fl_str_mv |
application/pdf 93-96 |
dc.source.none.fl_str_mv |
reponame:SEDICI (UNLP) instname:Universidad Nacional de La Plata instacron:UNLP |
reponame_str |
SEDICI (UNLP) |
collection |
SEDICI (UNLP) |
instname_str |
Universidad Nacional de La Plata |
instacron_str |
UNLP |
institution |
UNLP |
repository.name.fl_str_mv |
SEDICI (UNLP) - Universidad Nacional de La Plata |
repository.mail.fl_str_mv |
alira@sedici.unlp.edu.ar |
_version_ |
1844616188481503232 |
score |
13.070432 |